Company news
MediPharm Labs Corp. news in 2022
MediPharm Labs Corp.'s news releases, calls and decks from 2022, newest first.
MediPharm Labs Corp. to Acquire VIVO Cannabis Inc.
December 22, 2022
MediPharm Labs Receives Award for CBD Brand of the Year
December 8, 2022
MediPharm Labs Sets Date to Report Third Quarter 2022 Financial Results
November 9, 2022
MediPharm Labs Completes Sale of Australian Facility for Proceeds of $7,250,000 AUD
October 7, 2022
MediPharm Labs Reports Second Quarter Results
August 15, 2022
MediPharm Labs Sets Date to Report Second Quarter 2022 Financial Results
August 11, 2022
MediPharm Labs Enters Cannabis Research Agreement with Keck School of Medicine of USC
August 9, 2022
MediPharm Labs Awarded Payment of $9.8M in Connection to a 2020 Statement of Claim Against a Previous Customer
July 27, 2022
MediPharm Labs Enters into $6.2M Purchase Agreement for the Sale of Australian Facility
July 11, 2022
MediPharm Labs Announces Voting Results From the 2022 Annual Meeting of Shareholders
June 30, 2022
MediPharm Labs Sets Date to Report First Quarter 2022 Financial Results
May 12, 2022
MediPharm Labs Names Experienced Pharma and Med Tech Executive David Pidduck, as CEO
April 20, 2022
MediPharm Labs Continues to Lead with Innovation - Launches CBG and Water-Soluble Products
April 5, 2022
MediPharm Labs Reports Fourth Quarter and Full Year 2021 Results
March 31, 2022
MediPharm Labs Sets Date to Report Fourth Quarter and Full Year 2021 Financial Results
March 29, 2022
MediPharm Labs Strengthens Recreational Business Adding Flower and Pre-Rolls to Portfolio - Acquires IP from Canadian Consumer Favourite, Shelter Cannabis Brands
March 22, 2022
MediPharm Labs Enters United States Pharmaceutical Market with Submission of FDA DMF
February 23, 2022